03 October 2017 : Original article
Induction of Artificial Pancreas in Liver Transplant Recipients: Preliminary Experience with an Insightful Message
Hironori Hayashi1ABCDEFG*, Hiroyuki Takamura1ACDFG, Ryosuke Gabata1B, Isamu Makino1BC, Yoshinao Ohbatake1BC, Shinichi Nakanuma1BC, Tomoharu Miyashita1CD, Hidehiro Tajima1CDF, Kazuhiro Hanazaki2ADEF, Tetsuo Ohta1ADFGDOI: 10.12659/AOT.906083
Ann Transplant 2017; 22:590-597
Abstract
BACKGROUND: We investigated the impact of using an artificial pancreas for glycemic control in liver transplant recipients.
MATERIAL AND METHODS: Between January 2014 and December 2016, glycemic control using an artificial pancreas was performed 13 times. The target blood glucose level was set at 80–110 mg/dL. We retrospectively analyzed the clinical course, including achievement rate of the target blood glucose range.
RESULTS: For perioperative glycemic control, an artificial pancreas was used 9 times. The total insulin dose and achievement rate of the target blood glucose level were 113.9±51.4 U and 23.7±15.6%, per 24 h, respectively. Additionally, recipients with infectious complications (n=2) and rejection treated with methylprednisolone pulse therapy (n=2) received glycemic control using an artificial pancreas. The total insulin dose and achievement rate of the target blood glucose level were 156.5±57.5 U and 20.2±20.0% per 24 h, respectively. No hypoglycemia occurred during this period.
CONCLUSIONS: Application of an artificial pancreas for liver transplant recipients was safe, with no hypoglycemia. The results suggest that occurrence of marked insulin resistance in liver transplant recipients should be prevented for better outcomes.
Keywords: Diabetes Mellitus, Insulin Resistance, Liver Transplantation, Postoperative Complications
In Press
20 Mar 2024 : Original article
Transplant Nephrectomy: A Comparative Study of Timing and Techniques in a Single InstitutionAnn Transplant In Press; DOI: 10.12659/AOT.942252
28 Mar 2024 : Original article
Association Between FEV₁ Decline Rate and Mortality in Long-Term Follow-Up of a 21-Patient Pilot Clinical T...Ann Transplant In Press; DOI: 10.12659/AOT.942823
02 Apr 2024 : Original article
Liver Transplantation from Brain-Dead Donors with Hepatitis B or C in South Korea: A 2014-2020 Korean Organ...Ann Transplant In Press; DOI: 10.12659/AOT.943588
02 Apr 2024 : Original article
Effect of Dexmedetomidine Combined with Remifentanil on Emergence Agitation During Awakening from Sevoflura...Ann Transplant In Press; DOI: 10.12659/AOT.943281
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860